NDC 41163-351

Equaline

Ranitidine

Equaline is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Supervalu Inc.. The primary component is Ranitidine Hydrochloride.

Product ID41163-351_b15d3c38-c3b9-4830-9e4e-7eee66b3b782
NDC41163-351
Product TypeHuman Otc Drug
Proprietary NameEqualine
Generic NameRanitidine
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2011-06-28
Marketing CategoryANDA / ANDA
Application NumberANDA200536
Labeler NameSupervalu Inc.
Substance NameRANITIDINE HYDROCHLORIDE
Active Ingredient Strength150 mg/1
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 41163-351-50

1 BOTTLE in 1 CARTON (41163-351-50) > 50 TABLET in 1 BOTTLE
Marketing Start Date2011-06-28
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 41163-351-50 [41163035150]

Equaline TABLET
Marketing CategoryANDA
Application NumberANDA200536
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-06-28
Inactivation Date2020-01-31

NDC 41163-351-65 [41163035165]

Equaline TABLET
Marketing CategoryANDA
Application NumberANDA200536
Product TypeHUMAN OTC DRUG
Marketing Start Date2011-06-28
Inactivation Date2020-01-31

NDC 41163-351-24 [41163035124]

Equaline TABLET
Marketing CategoryANDA
Application NumberANDA200536
Product TypeHUMAN OTC DRUG
Billing UnitEA
Marketing Start Date2011-06-28
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
RANITIDINE HYDROCHLORIDE150 mg/1

OpenFDA Data

SPL SET ID:b15d3c38-c3b9-4830-9e4e-7eee66b3b782
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 198191

    • NDC Crossover Matching brand name "Equaline" or generic name "Ranitidine"

    NDCBrand NameGeneric Name
    41163-358EQUALINEEQUALINE
    41163-163EQUALINEEQUALINE
    41163-351EqualineEqualine
    41163-259EQUALINEEQUALINE
    41163-258EQUALINEEQUALINE
    41163-828EQUALINEEQUALINE
    41163-177EQUALINEEQUALINE
    10202-8527 Select Acid ReducerRanitidine
    0904-6350Acid ReducerRanitidine
    0113-7950basic care acid reducerRanitidine
    0113-7852basic care acid reducer 150Ranitidine
    0113-7876basic care acid reducer 75Ranitidine
    0113-0852Good Sense Acid ReducerRanitidine
    0113-0876Good Sense Acid ReducerRanitidine
    10202-712MAXIMUM STRENGTH RANITIDINERanitidine
    0597-0121Maximum Strength Zantacranitidine
    0121-0727RanitidineRANITIDINE
    0121-4727RanitidineRANITIDINE
    0172-4357RanitidineRanitidine
    0172-4358RanitidineRanitidine
    0363-0352RanitidineRanitidine
    0440-8300RanitidineRanitidine
    0440-8305RanitidineRanitidine
    0615-4513RanitidineRanitidine
    0615-4514RanitidineRanitidine
    0615-8021RanitidineRanitidine
    0781-6087RanitidineRanitidine
    0904-6349RanitidineRanitidine
    0904-6716RanitidineRanitidine
    0904-6921RanitidineRanitidine
    10544-056RanitidineRanitidine
    10544-438RanitidineRanitidine
    10544-516RanitidineRanitidine
    11673-849RanitidineRanitidine
    0904-6715ranitidine 75Ranitidine
    11673-023up and up ranitidineRanitidine
    0363-0852wal zan 150Ranitidine
    0363-0950wal zan 150Ranitidine
    0363-1876wal zan 75Ranitidine
    0363-0362Wal-ZanRanitidine
    0597-0122Zantac 75ranitidine
    0597-0120Zantac Maximum Strength 150 Cool Mintranitidine

    Trademark Results [Equaline]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    EQUALINE
    EQUALINE
    78379410 3177770 Live/Registered
    SUPERVALU LICENSING LLC
    2004-03-05
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.